טוען...
Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19
BACKGROUND: The effects of high-intensity immunity on coronavirus disease 2019 (COVID-19) remain unclear. Antibodies against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are preferentially induced in inpatients with COVID-19 compared with outpatients with milder disease, and immunosu...
שמור ב:
| הוצא לאור ב: | Int J Infect Dis |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8278827/ https://ncbi.nlm.nih.gov/pubmed/34273512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2021.07.015 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|